About DR. LAL PATHLABS LIMITED
DR. LAL PATHLABS LIMITED is a Public Limited Company and was incorporated on Feb 14, 1995 in India. It is registered at Registrar of Companies, ROC Delhi. Its registered address is Block E, Sector-18 Rohini, North West, NEW DELHI, Delhi, India, 110085. Its corporate identification number is (CIN) L74899DL1995PLC065388 and its current status is Active. Its industry classification as per MCA is other Business Activities. It had a team size of 5205 employees as on May 31, 2026.
DR. LAL PATHLABS LIMITED's last Annual General Meeting (AGM) was held on Jun 28, 2025 as per records from Ministry of Corporate Affairs (MCA). DR. LAL PATHLABS LIMITED's authorised share capital is ₹200Cr and its paid up capital is ₹83.8Cr. The current board of directors of DR. LAL PATHLABS LIMITED comprises Vandana Lal, Arvind Lal and 5 more.
DR. LAL PATHLABS LIMITED generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025.
Key Metrics
CIN
L74899DL1995PLC065388
Location
Current Status
Active
Entity Type
Public Limited Company
Date Of Incorporation
Feb 14, 1995
Company Age
31 Years 5 Months
Registrar of Companies
ROC - Delhi
Last AGM Date
Jun 28, 2025
Latest Revenue
₹1,000+ Cr as on Mar 31, 2025
Latest Employee Count
5,205 as on May 31, 2026
Authorized Capital
₹200Cr
Paid Up Capital
₹83.8Cr
Contact Details for DR. LAL PATHLABS LIMITED
- *****@lalpathlabs.com
- Registered Address
- Block E, Sector-18 Rohini, North West, NEW DELHI, Delhi, India, 110085
Brands associated with DR. LAL PATHLABS LIMITED
There are 3 brands associated with DR. LAL PATHLABS LIMITED which includes Dr Lal PathLabs , Suburban Diagnostics and Dr Lal PathLabs .
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Chain of pathology and radiology labs | 1949 | Public | ||
Chain of diagnostic labs | 1994 | Acquired | ||
Provider of diagnostic laboratory testing services including home sample collection | 2018 | Unfunded |
Principal Business Activity of DR. LAL PATHLABS LIMITED
The majority of DR. LAL PATHLABS LIMITED's turnover comes from Human health and social work activities.
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
Q | Human health and social work activities | 86 | Human health activities | tz{ |
Auditor Details of DR. LAL PATHLABS LIMITED
Here is the list of auditors of DR. LAL PATHLABS LIMITED:
Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
Deloitte Haskins & Sells LLP, Chartered Accountants | fzzvefd | pwktnyr | {fogpva |
Documents of DR. LAL PATHLABS LIMITEDFY 25 Available
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns | - |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form PAS-3 | Other eForm Documents | May 19, 2026 |
Optional attachment(s)- if any | Other eForm Documents | May 19, 2026 |
List of Allottees | Other eForm Documents | May 19, 2026 |
Form MGT-6 | Other eForm Documents | May 12, 2026 |
Form MGT-6 | Other eForm Documents | Apr 21, 2026 |
Form MGT-6 | Other eForm Documents | Apr 08, 2026 |
Form MGT-6 | Other eForm Documents | Mar 17, 2026 |
Form MGT-6 | Other eForm Documents | Mar 12, 2026 |
Form MGT-6 | Other eForm Documents | Mar 09, 2026 |
Form MGT-6 | Other eForm Documents | Feb 23, 2026 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available
Financials of DR. LAL PATHLABS LIMITEDFY 25 Available
DR. LAL PATHLABS LIMITED generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of DR. LAL PATHLABS LIMITED has a compounded annual growth rate (CAGR) of 11% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 8479 | 6766 | 5381 | 6514 | 5762 |
Total Sales | 3143 | 6117 | 4286 | 1208 | 1179 |
Total Expenses | 5445 | 3138 | 1076 | 3552 | 8723 |
Operating Expenses | 2274 | 4422 | 1954 | 8849 | 5285 |
Employee Expenses | 2552 | 9876 | 7221 | 7931 | 6000 |
Marketing Expenses | 4013 | 7883 | 6329 | 4718 | 4317 |
Operating Income (EBIT) | 5149 | 3627 | 3659 | 9444 | 2814 |
Interest Expenses | 3270 | 9704 | 4938 | 9963 | 5405 |
Expenses from other activities | 6873 | 1084 | 4062 | 7744 | 5611 |
EBITDA | 7494 | 9883 | 9438 | 3548 | 3899 |
Taxes | 5523 | 1295 | 3085 | 1042 | 3809 |
Net Profit | 6126 | 1666 | 4763 | 4443 | 4113 |
Balance Sheet | |||||
Assets | 3923 | 9035 | 5256 | 3579 | 5943 |
Cash Equivalent | 3703 | 2611 | 2018 | 6249 | 7472 |
Accounts Receivables | 7614 | 8087 | 8566 | 4494 | 9064 |
Inventory | 8181 | 7309 | 8928 | 1829 | 9655 |
Liabilities | 5457 | 6055 | 6461 | 5350 | 9086 |
Total Debt | 4419 | 5649 | 5508 | 5739 | 3703 |
Accounts Payable | 1701 | 6388 | 3358 | 5410 | 3752 |
Equities | 3458 | 9342 | 3962 | 4952 | 4197 |
Cashflow Statement | |||||
Cash from Operating activities | 4089 | 1566 | 6988 | 6869 | 8657 |
Cash from Investing activities | 6037 | 3251 | 1614 | 2283 | 1917 |
Net cash from Financing activities | 6943 | 4888 | 3229 | 9041 | 4308 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 7059 | 9943 | 1278 | 8298 | 6837 |
EBIT Margin | 1274 | 9841 | 6923 | 7765 | 2562 |
Net Profit Margin | 1521 | 6638 | 7822 | 5351 | 3261 |
Return on Assets (ROA) | 4267 | 2507 | 6681 | 6441 | 2900 |
Return on Equity (ROE) | 7671 | 3922 | 7839 | 7428 | 9691 |
Return on Capital Employed | 1917 | 1435 | 1761 | 7798 | 2562 |
Return on Invested Capital | 1210 | 1002 | 5963 | 7726 | 5650 |
Efficiency Ratios | |||||
Asset Turnover | 1090 | 6593 | 1042 | 9203 | 9689 |
Receivables Turnover | 5546 | 4274 | 9806 | 4162 | 6256 |
Days Sales Outstanding | 8890 | 2751 | 5010 | 5832 | 1910 |
Inventory Turnover | 3017 | 1358 | 3100 | 5255 | 4157 |
Days Inventory Outstanding | 3862 | 8229 | 5738 | 2166 | 7386 |
Payables Turnover | 6212 | 4211 | 1267 | 9185 | 6407 |
Days Payables Outstanding | 4156 | 5994 | 1614 | 6379 | 6720 |
Liquidity Ratios | |||||
Current Ratio | 3315 | 4412 | 9268 | 1019 | 3389 |
Quick Ratio | 6012 | 4305 | 3066 | 1790 | 1632 |
Cash Ratio | 6587 | 6651 | 1748 | 6098 | 5036 |
Coverage Ratios | |||||
Cash Flow Coverage Ratio | 7536 | 7725 | 6717 | 2451 | 5005 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 6877 | 7378 | 8159 | 3368 | 2750 |
Debt Ratio | 8232 | 7169 | 2400 | 4211 | 1840 |
Net Debt | 9710 | 5776 | 6728 | 7302 | 8799 |
Interest Coverage Ratio | 4442 | 6808 | 5108 | 6998 | 9912 |
Debt Service Coverage Ratio | 1248 | 6985 | 6004 | 3593 | 5819 |
Net Debt/EBITDA | 9582 | 5629 | 6233 | 9969 | 1023 |
Solvency Ratios | |||||
Runway (in months) | 3909 | 4505 | 8479 | 9868 | 7892 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 3373 | 6794 | 8775 | 3288 | 7622 |
Earnings Growth Rate (CAGR) | 8582 | 6378 | 6693 | 3374 | 5864 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of DR. LAL PATHLABS LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 11% |
3 Year | 720 |
5 Year | 142 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 16% |
3 Year | 987 |
5 Year | 813 |
MSME Payment Delays by DR. LAL PATHLABS LIMITED
Loans and Charges on DR. LAL PATHLABS LIMITED
DR. LAL PATHLABS LIMITED
has taken 16 loans.
Here is a list of loans and charges on DR. LAL PATHLABS LIMITED:
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100594143 | ₹250Cr | atemgus | Jun 24, 2022 | xvnfbkj | |
100507112 | ₹40Cr | ywoxwbs | Nov 10, 2021 | fvttuln | |
100504850 | ₹185Cr | ashkjvw | Nov 09, 2021 | pwkqay{ | |
100399810 | ₹10Cr | ggomnzp | Dec 07, 2020 | zd{pzyu | |
10341761 | ₹10Cr | owajzhq | Jan 30, 2012 | ifxpsao | |
10275102 | ₹60Cr | yihlojv | Feb 22, 2011 | mrgjuki | |
10245865 | ₹76.5L | ejiqqjw | Sep 08, 2010 | dobgmpq | |
90059246 | ₹3.66Cr | hf{av{m | Aug 11, 2005 | swklvsh | |
90254387 | ₹11.7L | cyzdkai | Jul 26, 2004 | chwfmwd | |
90038770 | - | ₹93L | tbmmzwd | Feb 23, 2004 | petseld |
90255225 | ₹8.61L | qbdweox | Jan 12, 2004 | wcgy{aj | |
90038630 | - | ₹1.06Cr | {giqtjw | Jan 02, 2004 | wcf{lqv |
90037521 | - | ₹3.9Cr | ehqpunz | Sep 09, 2002 | uishxhn |
90035551 | - | ₹1Cr | ezdcifx | Dec 03, 1999 | uthmw{c |
90034384 | - | ₹1.94Cr | dizujbv | Nov 24, 1997 | guiivvb |
90239295 | - | ₹6.13L | iomobrr | Apr 19, 1988 | qxgkgvf |
To access detailed information on a company’s loans, borrowings, & registered charges, Buy Detailed Report
Credit Ratings of DR. LAL PATHLABS LIMITED
GSTIN Details of DR. LAL PATHLABS LIMITED
Board of Directors and Signatories of DR. LAL PATHLABS LIMITED
Board of Directors of DR. LAL PATHLABS LIMITED
Here is the list of current board of directors of DR. LAL PATHLABS LIMITED:
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Whole-time Director | Current | Feb 14, 1995 | 31 Years 5 Months | |
Whole-time Director | Current | Feb 14, 1995 | 31 Years 5 Months | |
Director | Current | Jul 22, 2005 | 20 Years 11 Months | |
Director | Current | Feb 08, 2019 | 7 Years 5 Months | |
Director | Current | May 17, 2019 | 7 Years 2 Months | |
Director | Current | Nov 08, 2022 | 3 Years 8 Months | |
Director | Current | Jul 27, 2023 | 2 Years 11 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Signatories of DR. LAL PATHLABS LIMITED
Here is the list of current signatories of DR. LAL PATHLABS LIMITED:
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Whole-time Director | Current | Aug 21, 2015 | 10 Years 10 Months | |
Director | Current | Sep 29, 2015 | 10 Years 9 Months | |
Director | Current | Feb 08, 2019 | 7 Years 5 Months | |
Director | Current | Aug 12, 2019 | 6 Years 11 Months | |
Whole-time Director | Current | Apr 01, 2020 | 6 Years 3 Months | |
Director | Current | Nov 08, 2022 | 3 Years 8 Months | |
Director | Current | May 07, 2023 | 3 Years 2 Months | |
Company Secretary | Current | May 26, 2023 | 3 Years 1 Month | |
Director | Current | Aug 16, 2023 | 2 Years 11 Months | |
Director | Current | Aug 16, 2023 | 2 Years 11 Months | |
CEO | Current | May 30, 2024 | 2 Years 1 Month | |
CEO | Current | Sep 04, 2024 | 1 Year 10 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Cross Directorships of DR. LAL PATHLABS LIMITED
DR. LAL PATHLABS LIMITED has directors who also hold positions in 27 other legal entities. The top 20 are listed below:
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
APL INSTITUTE OF CLINICAL LABORATORY & RESEARCH PRIVATE LIMITED CIN: U73100GJ2011PTC065333, India, Amalgamated | 289 | 918 | 725 | 344 |
DELTA RIA AND PATHOLOGY PVT LTD CIN: U85110MP1993PTC007849, India, Amalgamated | 103 | 766 | 117 | 561 |
ARCHANA PHARMACEUTICALS PRIVATE LIMITED CIN: U24232DL2009PTC186582, India, Active | 454 | 696 | 759 | 958 |
KALMATIA SANGAM TRAVELS PRIVATE LIMITED CIN: U74899DL1992PTC050368, India, Active | 652 | 734 | 333 | 549 |
SANYA CHEMICALS PVT LTD CIN: U24110MH1984PTC032782, India, Amalgamated | 308 | 776 | 732 | 597 |
BLUESTONE JEWELLERY AND LIFESTYLE LIMITED CIN: L72900KA2011PLC059678, India, Active | 358 | 661 | 474 | 154 |
Star Health And Allied Insurance Company Limited CIN: L66010TN2005PLC056649, India, Active | 910 | 808 | 177 | 966 |
SUBURBAN DIAGNOSTICS (INDIA) PRIVATE LIMITED CIN: U85110MH2002PTC136144, India, Dissolved under section 59(8) | 480 | 157 | 438 | 267 |
INDIRA IVF HOSPITAL LIMITED CIN: U85110MH2015PLC406059, India, Active | 831 | 441 | 829 | 400 |
YATRA ONLINE LIMITED CIN: L63040MH2005PLC158404, India, Active | 726 | 802 | 222 | 872 |
YATRA ONLINE LIMITED CIN: L63040MH2005PLC158404, India, Active | 537 | 838 | 585 | 907 |
STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED CIN: L66010TN2005PLC056649, India, Active | 257 | 826 | 289 | 621 |
ICICI BANK LIMITED CIN: L65190GJ1994PLC021012, India, Active | 248 | 106 | 456 | 917 |
MEDEX HEALTHCARE PRIVATE LIMITED CIN: U29297TG2005PTC046848, India, Amalgamated | 792 | 690 | 655 | 779 |
PALIWAL DIAGNOSTICS PRIVATE LIMITED CIN: U26914UP1997PTC022257, India, Active | 245 | 256 | 548 | 753 |
PALIWAL MEDICARE PRIVATE LIMITED CIN: U85110UP2006PTC031606, India, Amalgamated | 202 | 454 | 142 | 879 |
CHIMES AVIATION PRIVATE LIMITED CIN: U62200DL2007PTC159447, India, Active | 933 | 235 | 128 | 270 |
DOON MRI PRIVATE LIMITED CIN: U00000DL2001PTC109862, India, Active | 232 | 850 | 174 | 118 |
SELECT SYNERGIES AND SERVICES PRIVATE LIMITED CIN: U74120DL1970PTC005271, India, Active | 121 | 206 | 566 | 485 |
TLGS CONSULTING GROUP PRIVATE LIMITED CIN: U74999DL2022PTC393518, India, Active | 992 | 379 | 384 | 530 |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Legal Cases involving DR. LAL PATHLABS LIMITED
Employee Count of DR. LAL PATHLABS LIMITED
DR. LAL PATHLABS LIMITED has an employee count of 5205 as on May 31, 2026.
Date | Employee Count |
|---|---|
May 26 | 5205 |
Apr 26 | 688 |
Mar 26 | 151 |
Feb 26 | 562 |
Jan 26 | 855 |
Dec 25 | 743 |
Nov 25 | 379 |
Trademarks of DR. LAL PATHLABS LIMITED
Patents of DR. LAL PATHLABS LIMITED
Competitors & Alternates of DR. LAL PATHLABS LIMITED
There are 3 brands associated with DR. LAL PATHLABS LIMITED, including Dr Lal PathLabs, Suburban Diagnostics, and others. Here is the list of the Top 10 competitors of Dr Lal PathLabs ranked by Tracxn score:
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Dr Lal PathLabs 1949, Gurugram (India), Public | Chain of pathology and radiology labs | $13.9M | 78/100 | |
2nd | Provider of DNA sequencing, bioinformatics, and multiomics services | $264M | 71/100 | ||
3rd |  Orange Health 2020, Bengaluru (India), Series C | Chains providing at-home diagnostic testing and health checkup services | $77.1M | 69/100 | |
4th | Metropolis India 1981, Mumbai (India), Public | Chain of diagnostic centers | $232M | 68/100 | |
5th | Laboratory offering biomarker analysis | $17.3M | 53/100 | ||
6th | Lilac Insights 2011, Mumbai (India), Series A | Provider of genetic diagnostic advisory services for infant | $11M | 52/100 | |
7th | Sterling Accuris Diagnostics 2015, Ahmedabad (India), Series C | Chain of pathology labs | $41.7M | 51/100 | |
8th | Provider of a chain of diagnostic labs | $1.54M | 49/100 | ||
9th | CRL Diagnostics 2015, Delhi (India), Unfunded | Chain of pathology laboratory services | - | - | 49/100 |
10th | Dr Dangs Lab 1983, Delhi (India), Unfunded | Provider of diagnostic testing services in various medical specialties | - | - | 45/100 |
To view the full list of competitors of Dr Lal PathLabs and the other associated brands, Buy Detailed Report
News related to DR. LAL PATHLABS LIMITED
Media has covered brands linked with DR. LAL PATHLABS LIMITED for a total of 9 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.
•
Dr. Lal Pathlabs Acquires Shahbazkers Diagnostic Centre, Expands Diagnostic FootprintBusiness Upturn•May 01, 2026•Shahbaz Ker, Dr Lal PathLabs
•
Dr Lal Path Labs eyes volume growth for FY27 tests amid expansion plansLivemint•May 01, 2026•Dr Lal PathLabs
•
Dr Lal PathLab Standalone December 2025 Net Sales at Rs 632.10 cr, up 19.69% Y-o-YMoneycontrol•Mar 12, 2026•Dr Lal PathLabs
•
Dr Lal PathLabs Gears Up for Southern Expansion with Potential M&AMoneycontrol•Feb 12, 2026•Dr Lal PathLabs
•
•
•
Dr Lal PathLabs Enters Preventive Healthcare with ‘Sovaaka’ Wellness CentreCNBC-TV18•Dec 18, 2025•Dr Lal PathLabs
•
Dr Lal PathLabs Q2 profit rises 16%, declares ₹7 dividend and 1:1 bonusIndiaBlooms•Oct 31, 2025•Dr Lal PathLabs
•
Dr. Lal PathLabs enhances genomics with Illumina’s NovaSeq X SeriesBioSpectrum India•Jun 25, 2025•Dr Lal PathLabs, Illumina
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!FAQs about DR. LAL PATHLABS LIMITED
Explore our recently published Legal Entities
